4-Bromobenzo[d][1,3]dioxole-5-carbaldehyde, 97%, 1g

1,2-Bis(4-methoxyphenyl)ethyne, 95.0%, 100mg

N-(2,3-dihydro-1,4-benzodioxin-6-yl)-1H-imidazol-2-amine, 95.0%, 250mg

2-Methyl-7-(trifluoromethyl)quinoline, 95.0%, 100mg

2-Phenoxyethanol, min 99%, for synthesis, 250 ml, glass packaging

6-(Cyclohexylmethoxy)-9H-purin-2-amine, 95.0%, 10mg

GC capillary column ROTI®Cap-5, 30 m, 0.25 mm, 0.35 µm, 1 Piece(s)

1-Boc-3-Hydroxymethylpyrrolidine, 95.0%, 5g

6-[(4-Nitrobenzyl)thio]-9-beta-D-ribofuranosylpurine, 98.0%, 100mg

2,5-Dichlorobenzaldehyde, 97.0%, 500g

3-BROMO-5-CHLOROQUINOLINE, 95.0%, 250mg

1-Hydroxytetraphenylcylclopentadienyl(tetraphenyl-2,4-cyclopentadien-1-one)-mu-hydrotetracarbonyldiruthenium(II)100mg

(2R,4R)-2-methyltetrahydro-2H-pyran-4-ol, 98%, 500mg